Alterity Therapeutics Stock Analysis

Alterity Stock Analysis Notes

The company has price-to-book (P/B) ratio of 1.02. Some equities with similar Price to Book (P/B) outperform the market in the long run. Alterity Therapeutics recorded a loss per share of 1.84. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 9th of January 2023. Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimers disease, Huntington disease, Parkinsons disease, and other neurological disorders in Australia. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia. Alterity Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. For more info on Alterity Therapeutics please contact the company at 61 3 9349 4906 or go to https://alteritytherapeutics.com.

Alterity Therapeutics Investment Alerts

Alterity Largest EPS Surprises

View All Earnings Estimates

Alterity Stock Institutional Investors

Note, although Alterity Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Alterity Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.24 M.

Alterity Profitablity

Management Efficiency

Alterity Therapeutics has return on total asset (ROA) of (0.5266) % which means that it has lost $0.5266 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0447) %, meaning that it created substantial loss on money invested by shareholders. Alterity Therapeutics' management efficiency ratios could be used to measure how well Alterity Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of November 27, 2024, Return On Tangible Assets is expected to decline to -1.04. In addition to that, Return On Capital Employed is expected to decline to -1.49. At present, Alterity Therapeutics' Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 22.58, whereas Non Current Assets Total are forecasted to decline to about 177.5 K.

Technical Drivers

As of the 27th of November, Alterity Therapeutics shows the Standard Deviation of 3.96, risk adjusted performance of (0.04), and Mean Deviation of 2.92. Alterity Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Alterity Therapeutics standard deviation, as well as the relationship between the treynor ratio and potential upside to decide if Alterity Therapeutics is priced correctly, providing market reflects its regular price of 1.06 per share. Given that Alterity Therapeutics is a hitting penny stock territory we recommend to closely look at its jensen alpha.

Alterity Therapeutics Price Movement Analysis

Alterity Therapeutics Outstanding Bonds

Alterity Therapeutics Predictive Daily Indicators

Alterity Therapeutics Forecast Models

Alterity Therapeutics' time-series forecasting models are one of many Alterity Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Alterity Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Alterity Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Alterity shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Alterity Therapeutics. By using and applying Alterity Stock analysis, traders can create a robust methodology for identifying Alterity entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Alterity analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Alterity analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Alterity Therapeutics stock analysis indicators help investors evaluate how Alterity Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Alterity Therapeutics shares will generate the highest return on investment. By understating and applying Alterity Therapeutics stock analysis, traders can identify Alterity Therapeutics position entry and exit signals to maximize returns.

When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.